336 related articles for article (PubMed ID: 26671081)
21. Anti-glutamic acid decarboxylase limbic encephalitis without epilepsy evolving into dementia with cerebellar ataxia.
Mirabelli-Badenier M; Morana G; Pinto F; Uccelli A; Veneselli E; Battaglia FM; Biancheri R; Baglietto MG; Vincent A; Mancardi MM
Arch Neurol; 2012 Aug; 69(8):1064-6. PubMed ID: 22507885
[TBL] [Abstract][Full Text] [Related]
22. Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus.
Nakajima H; Nakamura Y; Inaba Y; Tsutsumi C; Unoda K; Hosokawa T; Kimura F; Hanafusa T; Date M; Kitaoka H
J Neuroimmunol; 2018 Apr; 317():84-89. PubMed ID: 29338930
[TBL] [Abstract][Full Text] [Related]
23. Disabling Central Paroxysmal Positioning Upbeat Nystagmus and Vertigo Associated With the Presence of Anti-Glutamic Acid Decarboxylase Antibodies.
Martins AI; Carvalho JN; Amorim AM; Geraldo A; Eggenberger E; Lemos J
J Neuroophthalmol; 2018 Mar; 38(1):32-35. PubMed ID: 28767521
[TBL] [Abstract][Full Text] [Related]
24. The neurological syndromes associated with glutamic acid decarboxylase antibodies.
Baizabal-Carvallo JF
J Autoimmun; 2019 Jul; 101():35-47. PubMed ID: 31000408
[TBL] [Abstract][Full Text] [Related]
25. Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies.
Muñiz-Castrillo S; Vogrig A; Joubert B; Pinto AL; Gonçalves D; Chaumont H; Rogemond V; Picard G; Fabien N; Honnorat J
Cerebellum; 2020 Oct; 19(5):715-721. PubMed ID: 32592031
[TBL] [Abstract][Full Text] [Related]
26. Neurological Syndromes Associated with Anti-GAD Antibodies.
Dade M; Berzero G; Izquierdo C; Giry M; Benazra M; Delattre JY; Psimaras D; Alentorn A
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456344
[TBL] [Abstract][Full Text] [Related]
27. Glutamic acid decarboxylase autoantibodies and neurological disorders.
Vianello M; Tavolato B; Giometto B
Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
[TBL] [Abstract][Full Text] [Related]
28. Clinical characteristics of GAD 65-associated autoimmune encephalitis.
Zhu F; Shan W; Lv R; Li Z; Wang Q
Acta Neurol Scand; 2020 Sep; 142(3):281-293. PubMed ID: 32416610
[TBL] [Abstract][Full Text] [Related]
29. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.
Vianello M; Tavolato B; Armani M; Giometto B
Cerebellum; 2003; 2(1):77-9. PubMed ID: 12882238
[TBL] [Abstract][Full Text] [Related]
30. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
Rakocevic G; Raju R; Dalakas MC
Arch Neurol; 2004 Jun; 61(6):902-4. PubMed ID: 15210528
[TBL] [Abstract][Full Text] [Related]
31. [Autoantibodies to GAD and autoimmune-mediated neurological diseases].
Mitoma H; Mizusawa H
Nihon Rinsho; 2013 May; 71(5):921-6. PubMed ID: 23777105
[TBL] [Abstract][Full Text] [Related]
32. Intrathecal-specific glutamic acid decarboxylase antibodies at low titers in autoimmune neurological disorders.
Sunwoo JS; Chu K; Byun JI; Moon J; Lim JA; Kim TJ; Lee ST; Jung KH; Park KI; Jeon D; Jung KY; Kim M; Lee SK
J Neuroimmunol; 2016 Jan; 290():15-21. PubMed ID: 26711563
[TBL] [Abstract][Full Text] [Related]
33. [A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody].
Kobayakawa Y; Tateishi T; Kawamura N; Doi H; Ohyagi Y; Kira J
Rinsho Shinkeigaku; 2010 Feb; 50(2):92-7. PubMed ID: 20196490
[TBL] [Abstract][Full Text] [Related]
34. [Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction].
Carra-Dalliere C; Thouvenot E; Bonafé A; Ducray F; Touchon J; Charif M
Rev Neurol (Paris); 2012 Apr; 168(4):363-6. PubMed ID: 22405456
[TBL] [Abstract][Full Text] [Related]
35. Clinical spectrum of glutamic acid decarboxylase antibodies in a Taiwanese population.
Kuo YC; Lin CH
Eur J Neurol; 2019 Nov; 26(11):1384-1390. PubMed ID: 31132202
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics of patients with cerebellar ataxia associated with anti-GAD antibodies.
Aguiar TS; Fragoso A; Albuquerque CR; Teixeira PF; Souza MV; Zajdenverg L; Alves-Leon SV; Rodacki M; Lima MA
Arq Neuropsiquiatr; 2017 Mar; 75(3):142-146. PubMed ID: 28355320
[TBL] [Abstract][Full Text] [Related]
37. [Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome].
Saiz A; Arias M; Fernández-Barreiro A; Mínguez A; Casamitjana R; Tolosa E; Graus F
Med Clin (Barc); 1998 Mar; 110(10):378-81. PubMed ID: 9567281
[TBL] [Abstract][Full Text] [Related]
38. Low-titer anti-GAD-antibody-positive cerebellar ataxia.
Nanri K; Niwa H; Mitoma H; Takei A; Ikeda J; Harada T; Okita M; Takeguchi M; Taguchi T; Mizusawa H
Cerebellum; 2013 Apr; 12(2):171-5. PubMed ID: 22923147
[TBL] [Abstract][Full Text] [Related]
39. Peculiar labeling of cultured hippocampal neurons by different sera harboring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab).
Vianello M; Giometto B; Vassanelli S; Canato M; Betterle C; Mucignat C
Exp Neurol; 2006 Dec; 202(2):514-8. PubMed ID: 16890938
[TBL] [Abstract][Full Text] [Related]
40. Centripetal Nystagmus, Slow Saccades, Cerebellar Ataxia, and Parkinsonism in a Patient With Anti-GAD65-Associated Stiff Person Syndrome Spectrum Disorder.
Hac NEF; Murphy OC; Butala AA; Newsome SD; Gold DR
J Neuroophthalmol; 2023 Jun; 43(2):273-276. PubMed ID: 36728609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]